物理治疗和家庭培训对帕金森综合征的影响:随机对照试验 (MobilityAPP) 的协议
Cecilia Raccagni1,2, Victoria Sidoroff2, Anisoara Paraschiv-Ionescu3
1Department of Neurology, Provincial Hospital of Bolzano (SABES-ASDAA), Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversität, Bolzano, Italy.
BMJ open
|May 1, 2024
概括
在非典型帕金森症患者中,以步态为重点的物理治疗 (GPT) 显著改善了步态性能. 这项研究将GPT与标准物理治疗 (SPT) 进行比较,以确认帕金森病和相关疾病的增强移动性和功能.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 运动障碍 运动障碍
背景情况:
- 步行和运动障碍是帕金森症的特征和严重的特征,特别是在多种系统缩 (MSA) 和渐进性超核性 (PSP) 等非典型形式中.
- 之前的试点研究表明,物理治疗和家庭练习可以改善MSA患者的步态参数.
- 需要严格评估有针对性的物理治疗干预措施,以改善这些衰弱条件下的步态.
研究的目的:
- 为了比较以步态为重点的物理治疗 (GPT) 与标准物理治疗 (SPT) 在改善步态性能方面的有效性.
- 评估GPT与SPT对帕金森病 (PD),MSA-P和PSP患者身体活动水平和临床结果的影响.
- 调查基于传感器的实验室步行参数和现实世界活动指标作为主要和次要结果.
主要方法:
- 这是一项双盲随机对照试验,每组疾病 (PD,MSA-P,PSP) 共有48名患者参与.
- 干预包括为期2周的住院物理治疗,随后是为期5周的无监督家庭运动计划.
- 通过可穿戴传感器测量步行参数和体力活动的结果,以及临床秤和患者问卷.
主要成果:
- 主要结果集中在基于传感器的实验室步态参数上.
- 二次结果包括现实世界的体力活动,临床评分尺度和患者报告的结果.
- 这项研究旨在量化因理疗干预而导致的移动性和功能改善.
结论:
- 这项试验将提供强有力的证据,证明以步行为重点的物理治疗对改善非典型帕金森症移动性的有效性.
- 这些发现将为临床实践提供信息,并指导PD,MSA-P和PSP患者开发最佳康复策略.
- 这项研究有助于理解基于传感器和现实世界的措施,以评估神经系统疾病中的步态干预措施.
相关概念视频
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Parkinson's Disease: Overview
537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
199
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
199


